Skip to main content

Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 5, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 5, 2024 -- Lung function remains stable over three years after hematopoietic cell transplant (HCT) among patients with sickle cell disease (SCD), according to a study published online June 26 in the Annals of the American Thoracic Society.

A. Parker Ruhl, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined pulmonary function testing parameters at three years after HCT. Data were obtained for 97 SCD patients who underwent HCT; 55 were available for follow-up at three years.

The researchers found that the median pre-HCT forced expiratory volume in one second (FEV1) was 68.3 and 69.2 percent at baseline and three years post-HCT; diffusing capacity of the lungs for carbon monoxide (DLCO) was 60.5 and 64.6 percent pre-HCT and at three years post-HCT. At three years post-HCT, generalized estimating equations estimated that DLCO percent-predicted increased significantly by 3.7 percent and the six-minute walk distance increased significantly by 25.9 m; relative to pre-HCT, no significant change was seen in percent-predicted FEV1 or forced vital capacity.

"Without the ongoing injury, it's possible that healing of lung tissue might occur, and this finding should help reassure adults living with sickle cell disease who are considering whether to have a low-intensity stem cell transplant procedure that their lung health will not be compromised by the transplant," Ruhl said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia

TUESDAY, April 29, 2025 -- For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical benefits in terms of reducing emergency department visits and hospital...

Air Pollution Exposure Negatively Impacts Some Domains of Cognitive Performance

TUESDAY, April 15, 2025 -- Air pollution is associated with domain-specific impacts on cognitive performance in older adults, according to a study published online March 17 in The...

C-Reactive Protein Increases During Menstrual Cycle in Females With Sickle Cell Disease

TUESDAY, April 15, 2025 -- For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.